Seelaus Asset Management LLC Cytosorbents Corp Transaction History
Seelaus Asset Management LLC
- $104 Million
- Q2 2025
A detailed history of Seelaus Asset Management LLC transactions in Cytosorbents Corp stock. As of the latest transaction made, Seelaus Asset Management LLC holds 18,300 shares of CTSO stock, worth $15,555. This represents 0.02% of its overall portfolio holdings.
Number of Shares
18,300
Previous 18,300
-0.0%
Holding current value
$15,555
Previous $18,000
27.78%
% of portfolio
0.02%
Previous 0.02%
Shares
10 transactions
Others Institutions Holding CTSO
# of Institutions
52Shares Held
16.7MCall Options Held
28.9KPut Options Held
0-
Avenir Corp Washington, DC5.06MShares$4.3 Million0.7% of portfolio
-
Skylands Capital, LLC2.62MShares$2.22 Million0.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.12MShares$1.81 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.59MShares$1.35 Million0.0% of portfolio
-
Cm Management, LLC1.25MShares$1.06 Million1.64% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $37M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...